Post-earnings recap
Reported
Mon, Mar 24, 2025
EPS actual
$-0.84
EPS est.
$-0.38
EPS surprise
-122.81%
1-day move
+5.59%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Centessa Pharmaceuticals faced significant challenges, as reflected in the EPS miss. Despite this, the stock rose by 5.59%, suggesting that investors may be optimistic about future developments or other aspects of the company's performance. The lack of revenue data and guidance leaves some uncertainty for investors moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.84 | N/A | -122.81% |
| Revenue | N/A | N/A | N/A |
Management's tone was defensive, reflecting on the difficulties encountered. They reiterated their focus on long-term objectives.
Management acknowledged the challenges faced during the quarter.
They emphasized a commitment to long-term goals despite current setbacks.